Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan. Journal Article


Authors: Gill, HS; Tade, F; Greenwald, DT; Yonover, PM; Savir-Baruch, B
Article Title: Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan.
Abstract: Prostate imaging with F-labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC, F-fluciclovine) PET/CT scan (Axumin) was recently approved by the US Food and Drug Administration for men with suspected prostate cancer recurrence based on elevated blood prostate-specific antigen levels following prior treatment. We present a rare case of a 77-year-old man with suspected recurrent prostate cancer with an incidental finding of advanced-stage breast cancer showing different degrees of F-fluciclovine uptake.
Journal Title: Clinical nuclear medicine
ISSN: 1536-0229; 0363-9762
Publisher: Unknown  
Date Published: 2018
LUC Authors
Related LUC Article